Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum

Core Insights - Rapid Micro Biosystems, Inc. is participating in the KeyBanc Capital Markets Healthcare Forum, highlighting its role in the life sciences technology sector [1] - The company will hold a virtual Q&A session on March 17, 2026, at 11:15 a.m. Eastern Time, with a live webcast available for investors [2] Company Overview - Rapid Micro Biosystems provides automation solutions for the efficient manufacturing and safe release of healthcare products, including biologics, vaccines, cell and gene therapies, and sterile injectables [3] - The flagship Growth Direct system modernizes microbial quality control testing workflows in pharmaceutical manufacturing, enhancing speed, accuracy, operational efficiency, and compliance with data integrity regulations [3] - The company is headquartered in Lexington, Massachusetts, with manufacturing in Lowell, Massachusetts, and additional locations in Switzerland, Germany, and the Netherlands [3]